Researchers at the Perelman School of Medicine at the University of Pennsylvania have been working on a preclinical study that focuses on a novel strategy that uses a "one-two punch" to assist T cells in attacking solid tumours. The results, which were reported in the Proceedings of the Nati
An advanced imaging method is showing promise as a way to improve the diagnosis of prostate cancer by giving clinicians a clearer view of suspected tumours during biopsy.
An advanced imaging approach is showing promise in improving prostate cancer detection by providing doctors with a clearer image of suspected tumours during the biopsy.
Experiments on mice and human cells reveal that the number of specialised immune cells ready to combat skin cancer increased when a novel therapy prevented their egress from melanoma tumours.
A very uncommon but frequently aggressive type of brain tumour called a glioma may be caused by damage, according to key molecular research from the UCL Cancer Centre. Although there may be a connection between head trauma and an increase in brain tumour incidence, the evidence is conflictin
Researching the wall separating the circulatory system from the neurological system has been highly difficult or limited in its use of models. In order to properly investigate potential new treatments for brain tumours, researchers have created a more realistic model.
Researchers have discovered a previously unidentified function of "natural killer" (NK) immune cells, which has increased our understanding of how the immune system is controlled to prevent disease.
Gene mutations are the cause of cancer. Tumor suppressors and oncogenes are the two main groups of these altered genes in cancer. Mutations in oncogenes can drive cell proliferation, pushing the gas pedal all the way to the floor, whereas mutations in tumour suppressor genes can cause tumour
Cancer is a disease driven by gene mutations. These mutated genes in cancer fall into two major categories: tumour suppressors and oncogenes. Mutations in tumour suppressor genes can allow tumours to grow unchecked - a case of no brakes - while mutations in oncogenes can activate cell prolif
Some cancers respond well to immunotherapy, a medication therapy that prompts the immune system to target tumours, although results against lung cancer have been conflicting.
The presence of a brain tumour can be determined by identifying a crucial membrane protein in urine, according to research from Nagoya University in Japan. By eliminating the need for intrusive tests and raising the possibility that tumours are found early enough for surgery, their protein m